Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07094308 · ClinicalTrials.gov registry record · NA

The LIFT-ECHO Last Mile Project

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Not yet
Registry status
NA
Development phase
150
Enrollment target

NCT07094308 is a NA study that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07094308, a NA study, has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.

NOT YET RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

This is a multi-site research study to evaluate the efficacy and effectiveness of the LIFT-ECHO program to improve clinical outcomes in patients and improve patient reported quality of life (PRQOL). LIFT-ECHO (Learn Intestinal Failure Tele-ECHO) is a tele-health learning program whereby non-specialist clinicians meet with and learn from CIF specialist teams with the goal of improving the knowledge of CIF. LIFT-ECHO sessions consist of group discussion of anonymized real-world patient cases, followed by a didactic presentation from an expert in intestinal failure. Sessions are held twice a month and last 60-90 minutes. The study will proceed in three distinct phases, correlating with Project Aims. During phase 1 (Aim 1), an intestinal failure disease activity index (IF-DAI) will be developed as a measure of short- to medium-term clinical activity in CIF patients; this phase will be undertaken through Delphi Rounds. During Phase 2 (corresponding to project Aim 2), the researchers will evaluate the impact of physician participation in LIFT-ECHO on patients with CIF on PN. Lastly, Phase 3, corresponding to Aim 3 will be the dissemination of LIFT-ECHO nationally. For Phase 2, the researchers had originally proposed that patients and physicians will be recruited from the records of Optum Home Infusion services. Patient reported quality of life and clinical status will be assessed using surveys at baseline. Physicians will then be invited to participate in a module of LIFT-ECHO consisting of 8 one- hour-long sessions held over the course of 2-4 months. Patients will then be followed for 12 months to assess if physician participation in LIFT-ECHO improves patient reported quality of life and/or treatment efficacy and effectiveness. The main procedures for physician participants in the study include: completion of baseline and monthly surveys, possible participation in an appreciative inquiry workshop and possible participation in a focus group discussion, optional, but enco

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Learn Intestinal Failure Tele-ECHO Program

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-07-01
Est. Completion 2030-06-30
Phase NA

What the Registry Record Tells You About NCT07094308

The ClinicalTrials.gov registry entry for NCT07094308 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT07094308 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07094308 about?

NCT07094308 is a clinical study titled "The LIFT-ECHO Last Mile Project". This is a multi-site research study to evaluate the efficacy and effectiveness of the LIFT-ECHO program to improve clinical outcomes in patients and improve patient reported quality of life (PRQOL). LIFT-ECHO (Learn Intestinal Failure Tele-ECHO) is a tele-health learning program whereby non-speciali...

What is the current status of trial NCT07094308?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-07-01. Estimated completion is 2030-06-30.

What interventions are being tested in trial NCT07094308?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Learn Intestinal Failure Tele-ECHO Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07094308?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.